- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
From Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
From Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Background:
Health literacy is defined by the Institute of Medicine as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make informed health decisions.1 Low health literacy affects 25% of patients with CKD and is associated with increased morbidity and death.2 The annual global incidence of IgA nephropathy (IgAN) is 2.5 cases/100,000; however this varies by region and ethnicity.3 The annual US incidence is around 1.29/100,000 persons.4
Did You Know?
- Nearly 9 in 10 adults in America have trouble understanding some or all the health information they receive from HCPs or publicly.5
- Many patients with IgAN have lost nearly 50% of their kidney function at the time of diagnosis.6
Why Attend This Webinar?
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss some of the challenges in her own practice. We will discuss how differing levels of health literacy can impact the patient journey during presentation, diagnosis, prognosis, and management, including access to care.
What You Will Learn
- What is health literacy and how it relates to kidney disease and the patient journey in IgAN.
- Clinical features, diagnosis, and prognosis of IgAN and how differing levels health literacy can impact patient outcomes.
- How healthcare professionals can support patients with differing levels of health literacy.
References:
- Jain D, et al. World J Nephrol. 2016;5(2):147-151.
- Campbell ZC, et al. Cochrane Database Syst Rev. 2022;12(12):CD012026. March 2025 US.CORP.X.25.00051
- McGrogan A et al. Nephrol Dial Transplant. 2011 ;26(2) :414-430
- Kwon CS et al. J Health Econ Outcomes Res. 2021;8(2):36-45
- US Department of Health and Human Services (DHHS), Office of Disease Prevention and Health Promotion. National action plan to improve health literacy. Washington, DC: Author. https://odphp.health.gov/sites/default/files/2019-09/Health_Literacy_Action_Plan.pdf. Published 2010. Assessed 3/18/25
- Kwon CS, et al. J Health Econ Outcomes Res. 2021;8(2):36-45
Speakers
Maria-Gabriela Velez, MD, PhD
Nephrologist, Kidney Associates of ColoradoMaria-Gabriela Velez, M.D., Ph.D, is a trained physician scientist with a special interest in diabetic kidney disease and inflammatory/autoimmune diseases of the kidney. Dr. Velez completedmedical training and obtained her doctorate in immunology at the University of Colorado School of Medicine. Her doctoral thesis was focused on B cell biology; more specifically B cell development, negative selection and differentiation, under the mentorship of Dr. Roberta Pelanda.
She then completed her training in internal medicine and her fellowship in nephrology at Stanford University.
Dr. Velez returned to Colorado to join Kidney Associates of Colorado in 2015. She uses her extensive medical experience and Spanish-speaking skills to provide comprehensive treatment options and dialysis education to the Hispanic community. Dr. Velez has volunteered and worked in community health clinics, having been recognized for helping increase access to health care.
Moderators
Lisa Voigt, PharmD, BCPS, BCCCP
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Lisa Voigt, PharmD, BCPS, BCCCP is a PharmD who works as a Senior Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.
Maria-Gabriela Velez, MD, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Lisa Voigt, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.
March 2025 US.CORP.X.25.00051Registration
Related Events
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
